Letter from the national AIDS and STI control programme of Ghana to Danaher to reduce the price of the GeneXpert HIV and hepatitis test

MSF sent another open letter urging AbbVie to make glecaprevir/pibrentasvir (G/P) accessible for people with hepatitis C in LMICs

Médecins Sans Frontières (MSF) Access Campaign wrote an open letter to pharmaceutical corporation AbbVie to express our urgent need for glecaprevir/pibrentasvir (G/P) combination to treat people with hepatitis C.

Médecins Sans Frontières (MSF) Access Campaign wrote a letter of support to the Malaysian government commending the issuance of a government use licence to enable access to an affordable version of the hepatitis C drug sofosbuvir. The ...

The grounds for opposing patent applications for velpatasvir

This issue brief provides information on currently available hepatitis C diagnostics and treatments, including pricing and registration information from manufacturers of direct-acting antivirals (DAAs). Reasons underlying the continued ...

Médecins Sans Frontières/Doctors Without Borders (MSF) plans to start treating people infected with hepatitis C virus in nine countries.